Home > Income Statement > NATCO PHARMA

NATCO PHARMA
Operating Profit

    Back to Income Statement
NATCO PHARMA is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Top Undervalued Small Cap Stocks
AD     Remove this Ad

NATCO PHARMA Last 5 Year Operating Profit History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Operating Profit (Excl OI) ₹2,194 Cr₹1,751 Cr₹912 Cr₹264 Cr₹604 Cr

What is the latest Operating Profit of NATCO PHARMA ?

The latest Operating Profit ratio of NATCO PHARMA is ₹2,194 Cr based on Mar2025 Consolidated results.
Year Operating Profit
Mar2025₹2,194 Cr
Mar2024₹1,751 Cr
Mar2023₹912 Cr
Mar2022₹264 Cr
Mar2021₹604 Cr

How is Operating Profit of NATCO PHARMA Trending?

Years Operating Profit % Change
Mar2025 ₹2,194 Cr
25.26
Mar2024 ₹1,751 Cr
92.10
Mar2023 ₹912 Cr
246.00
Mar2022 ₹264 Cr
-56.36
Mar2021 ₹604 Cr -

Compare Operating Profit of peers of NATCO PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NATCO PHARMA ₹19,551.5 Cr -1.8% 7.5% 40.5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹407,083.0 Cr -1% -7% -1% Stock Analytics
DIVIS LABORATORIES ₹163,971.0 Cr 5% -2.7% 15.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹140,660.0 Cr 3.2% -6.2% 29.3% Stock Analytics
DR REDDYS LABORATORIES ₹101,686.0 Cr 2.3% -8.1% 13.5% Stock Analytics
CIPLA ₹99,086.7 Cr 0.9% -7.8% -12.5% Stock Analytics


NATCO PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
NATCO PHARMA

-1.8%

7.5%

40.5%

SENSEX

4.7%

-0.1%

3.6%


You may also like the below Video Courses